Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)
Claude Preudhomme(Centre National de la Recherche Scientifique), Hervé Dombret(University of London Institute in Paris), Stéphane de Botton(Université Paris-Sud), Charlotte Lamandin(Inserm), Emmanuel Raffoux(Université Paris Cité), Xavier Thomas(Hôpital Lyon Sud), Nicolas Boissel(Hôpital Saint-Louis), Isabelle Tigaud(Inserm), C. Sagot(Inserm), Sylvie Castaigné(Université Claude Bernard Lyon 1), Jean‐Michel Cayuela(Inserm), Pierre Fenaux(Hôpital Avicenne)
Cited by 503
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k